Literature DB >> 20981505

Postprandial lipemia detects the effect of soy protein on cardiovascular disease risk compared with the fasting lipid profile.

Antonio S Santo1, Ariana M Santo, Richard W Browne, Harold Burton, John J Leddy, Steven M Horvath, Peter J Horvath.   

Abstract

Studies examining the effect of soy protein on cardiovascular disease (CVD) risk factors have not taken advantage of the postprandial state as an adjunct to the fasting lipid profile. The American Heart Association has acknowledged the efficacy of soy protein in reducing CVD risk factors to be limited. We hypothesized that the postprandial state would be more sensitive to any favorable changes associated with consuming soy protein compared with the fasting lipid profile. Furthermore, the presence of isoflavones in soy would enhance this effect. Thirty sedentary males aged 18-30 years were randomly assigned to milk protein (Milk), isoflavone-poor soy (Soy-), or isoflavone-rich soy (Soy+). Usual diets were supplemented with 25 g/day of protein for 28 days. Serum samples were collected before and after supplementation in a fasted state and postprandially at 30, 60, 120, 240, and 360 min after a high-fat, 1,000 kcal shake. Triacylglycerol (TAG), total cholesterol, non-esterified fatty acids, apolipoproteins B-100 and A-I and glucose concentrations were quantified. Fasting concentrations were not different after any protein supplementation. Postprandial TAG and TAG AUC increased after Soy-consumption supporting the postprandial state as a more sensitive indicator of soy ingestion effects on CVD risk factors compared with the fasting lipid profile. Furthermore, the absence of isoflavones in soy protein may have deleterious consequences on purported cardio-protective effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20981505     DOI: 10.1007/s11745-010-3487-z

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  62 in total

1.  Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee.

Authors:  Frank M Sacks; Alice Lichtenstein; Linda Van Horn; William Harris; Penny Kris-Etherton; Mary Winston
Journal:  Circulation       Date:  2006-01-17       Impact factor: 29.690

2.  Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women.

Authors:  K E Wangen; A M Duncan; X Xu; M S Kurzer
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

3.  Effect of soy protein-containing isoflavones on lipoproteins in postmenopausal women.

Authors:  Jerilyn K Allen; Diane M Becker; Peter O Kwiterovich; Kathleen A Lindenstruth; Carol Curtis
Journal:  Menopause       Date:  2007 Jan-Feb       Impact factor: 2.953

Review 4.  Nutritional and health benefits of soy proteins.

Authors:  M Friedman; D L Brandon
Journal:  J Agric Food Chem       Date:  2001-03       Impact factor: 5.279

Review 5.  Postprandial lipoproteins and atherosclerosis.

Authors:  K C Yu; A D Cooper
Journal:  Front Biosci       Date:  2001-03-01

Review 6.  Clinical review: a critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations.

Authors:  Antonella Dewell; Piper L W Hollenbeck; Clarie B Hollenbeck
Journal:  J Clin Endocrinol Metab       Date:  2005-12-29       Impact factor: 5.958

7.  Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region.

Authors:  A Patel; F Barzi; K Jamrozik; T H Lam; H Ueshima; G Whitlock; M Woodward
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

Review 8.  Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans.

Authors:  L J Lu; K E Anderson
Journal:  Am J Clin Nutr       Date:  1998-12       Impact factor: 7.045

Review 9.  Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders.

Authors:  Nimbe Torres; Ivan Torre-Villalvazo; Armando R Tovar
Journal:  J Nutr Biochem       Date:  2005-12-05       Impact factor: 6.048

10.  NMR analysis of lipoprotein particle size does not increase sensitivity to the effect of soy protein on CVD risk when compared with the traditional lipid profile.

Authors:  Antonio S Santo; Ariana M Cunningham; Sofiya Alhassan; Richard W Browne; Harold Burton; John J Leddy; Peter W Grandjean; Steven M Horvath; Peter J Horvath
Journal:  Appl Physiol Nutr Metab       Date:  2008-06       Impact factor: 2.665

View more
  1 in total

Review 1.  Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview.

Authors:  Lotte Smolders; Jogchum Plat; Ronald P Mensink
Journal:  J Nutr Metab       Date:  2017-06-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.